

Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health. Among its major competitors, Evofem Biosciences is ranked in 5th place for NPS while AMAG Pharmaceuticals is 1st, and Teva Pharmaceutical Industries is 2nd.Their current market cap is $119.07M